Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …

Hypertension is defined as a persistently elevated blood pressure≥ 140/90 mm Hg. It is an
important treatable risk factor for cardiovascular disease, with a high prevalence in the …

Objective To describe clinical practice experience of 11C‐Metomidate PET/CT as an adjunct
to adrenal vein sampling (AVS) in the lateralization of aldosterone‐producing adenomas …

Primary aldosteronism (PA) is a potentially curable form of secondary hypertension caused
by excessive renin-independent aldosterone secretion, leading to increased target organ …

Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary
hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has …

The complexity of evaluating patients for secondary treatable causes of hypertension is
underappreciated. Primary aldosteronism (PA) is the most prevalent cause of secondary …

The β-adrenoceptor blockers may have anti-oxidant properties or induce β-arrestin
recruitment beyond classical desensitization of receptor/G protein coupling, offering …

The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism
in hypertensives. However, patients often use medications that could confound the ARR …

Introduction Hyperglycaemia increases succinate concentrations and succinate receptor
activation in the kidney resulting in renin release. The aim of our study was to determine if …

Objective To investigate how often target renin is pursued and achieved in patients with
primary aldosteronism (PA) and other low renin hypertension (LRH) treated with …